Alarm over genetic control of embryos
By [Letter to the editor],
The Times [UK]
| 03. 20. 2013
[Letter to the editor]
Sir, We are writing in regard to the HFEA’s recent consultation on what it calls “mitochondrial replacement”, about which we have a number of serious ethical concerns.
In the procedures being proposed, the chromosomes of unfertilised eggs or of newly conceived embryos are, in fact, replaced, and these are clearly examples, therefore, of germ-line genetic manipulation. The reconstructed egg or embryo will have an altered genetic composition that will be inheritable. It would be the first time such intentional genetic modifications of children and their descendants were expressly permitted and would open the door to further genetic alterations of human beings with unforeseeable consequences.
Chromosomal replacement would cross the Rubicon into germ-line genetic interventions. Moreover, we are concerned that these proposals for research and possible treatment which rely on egg donation will greatly increase the possibilities for the exploitation of egg donors.
Because of the implications for all of humanity, intentional germ-line interventions are prohibited in every national jurisdiction that has considered the issue. They are also banned under a number of international legal instruments, such as the Council of...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...